tiprankstipranks

Michael Bonney Insider Profile

11 Followers
Michael Bonney, CEO, Director at Cubist Pharma, holds 0.00 shares in Cubist Pharma (Ticker: CBST), holds 0.00 shares in Global Blood Therapeutics (Ticker: GBT), holds 9.13K shares in Sarepta Therapeutics (Ticker: SRPT).
tipranks
Michael Bonney

Michael Bonney
Cubist Pharma (CBST)
CEO, Director

Ranked #62,297 out of 98,743 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

-6.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
50.92%
30.29%
12.02%
6.29%
0.49% Others
A breakdown of Michael Bonney's holdings

Insider Roles

Dianthus Therapeutics
(DNTH)
Director
Alnylam Pharma
(ALNY)
Director
Sarepta Therapeutics
(SRPT)
Director
Bristol-Myers Squibb
(BMY)
Director
+4 other positions
Roles that Michael Bonney holds in companies

Most Profitable Insider Trade

Stock:
Sarepta Therapeutics
(SRPT)
Rating:Informative Buy
Date:Sep 09, 2019 - Sep 09, 2020
Return:+50.60%
The most profitable trade made by Michael Bonney

Michael Bonney's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CBST
Cubist Pharma
Jan 21, 2015
Uninformative Sell
18.73M
GBT
Global Blood Therapeutics
$0.00
Sarepta Therapeutics
Feb 28, 2020
Director
Uninformative Buy
$1.21M
Syros Pharmaceuticals
Director
Dianthus Therapeutics
Jun 27, 2018
Director
Uninformative Buy
$5.13M
Kaleido Biosciences
Mar 04, 2019
Director
Uninformative Buy
$16.51K
Bristol-Myers Squibb
Jun 14, 2021
Director
Uninformative Buy
$633.26K
Alnylam Pharma
Aug 04, 2023
Director
Uninformative Buy
1.20M
$3.05M
CELG
Celgene
Nov 22, 2019
Uninformative Sell
$0.00
NPSP
NPS Pharma
Feb 24, 2015
Uninformative Sell
639.40K
Tekla Healthcare Investors of Benef Interest
Director
$0.00
Tekla Life Sciences Investors of Benef Interest
Jun 30, 2014
Director
Informative Buy
28.82K
$32.72K
List of latest transactions for each holding click on a transaction to see Michael Bonney's performance on stock

Michael Bonney insider profile FAQ

What is the percentage of profitable transactions made by Michael Bonney?
The percentage of profitable transactions made by Michael Bonney is 50%.
    What is the average return per transaction made by Michael Bonney?
    The average return per transaction made by Michael Bonney is -6.40%.
      What stocks does Michael Bonney hold?
      Michael Bonney holds: CBST, GBT, SRPT, SYRS, DNTH, KLDO, BMY, ALNY, CELG, NPSP, HQH, HQL stocks.
        What was Michael Bonney’s latest transaction?
        Michael Bonney latest transaction was an Uninformative Sell of $18.73M.
          What was Michael Bonney's most profitable transaction?
          Michael Bonney’s most profitable transaction was an Informative Buy of SRPT stock on September 9, 2019. The return on the trade was 50.60%.
            What is Michael Bonney's role in Cubist Pharma?
            Michael Bonney's role in Cubist Pharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.